$ATXI Cashflow Statement | Understand Stock

$ATXI

$0.54 -$0.03 (4.48%) Close

$ATXI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Reconciliation of net loss to net cash used in operating activities:
Share based compensation
Loss on common stock warrant liabilities
Change in fair value of warrant liability
Common shares issuable - Founders Agreement
Issuance of Stock Under Founders Agreement
Common Stock, Issued to Fortress, Value
Issuance of Stock for Licenses Acquired
Research and Development License, Acquired Expense
License Expenses Paid In Kind
Gain on repurchase of common stock held by AnnJi
Issuance of common stock of subsidiary

Changes in operating assets and liabilities:
Other receivables - related party
Prepaid expenses and other current assets
Accounts payable and accrued expenses
Nonrelated Party
Related Party
Total accounts payable and accrued expenses

Accounts payable and accrued expenses - related party
Net cash and cash equivalents used in operating activities

Purchase of research and development licenses
Cash flows from financing activities:
Proceeds from ATM sales of common stock, net of issuance costs
Proceeds from issuance of common stock, warrants, and pre-funded warrants, net of issuance costs
Repurchase of common stock held by InvaGen
Proceeds from exercise of warrants
Payment of offering costs
Warrant exercise transaction costs
Net cash provided by financing activities
Net change in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period

Supplement disclosure of non-cash information:
Receipt of interest in Baergic from Fortress
Unpaid offering costs
Baergic deconsolidation
Issuance of common shares - Founders Agreement

Comments